Merck KGaA, Darmstadt, Germany /
Bio-Techne Corporation
Merck KGaA, Darmstadt, Germany signed an agreement for Bio-Techne Corporation.
Source for the buyer and target: Bio-Techne Corporation
For the buyer and target.
“On June 25, 2026, Bio-Techne Corporation, a Minnesota corporation (“ Bio-Techne ”), agreed to be acquired by Merck KGaA, Darmstadt, Germany, a German corporation with general partners (“ Parent ”) on the terms and subject to the conditions set forth in the Merger Agreement (as defined below).”
Published 20 Aug 2026
Open the sourceWhat happened
The deal for Bio-Techne Corporation is signed, with Merck KGaA, Darmstadt, Germany as the buyer, at a stated price of $73.00 per share. [01]
The filing from Bio-Techne Corporation is dated Aug. 20, 2026. [01]
Who is involved, and the source
Everything on this page comes from the source below, quoted word for word.
Advisers
Target
- Fairness opinion to the targetBio-Techne’sSource: SEC filing, as of 20 Aug 2026
- Fairness opinion to the targetGoldman SachsSource: SEC filing, as of 20 Aug 2026
- Financial adviser to the targetGoldman SachsSource: SEC filing, as of 20 Aug 2026
Each adviser in its source's own words. An adviser's own announcement is labelled as one: it is not independent reporting. Advisers are not parties to the deal.
Merck KGaA, Darmstadt, Germany signed an agreement for Bio-Techne Corporation.
This document is the source for the companies, stage, figure and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly